Grant Avenue launches new integrated clinical site organisation
Gastrointestinal
Redx Pharma previews development plans for idiopathic pulmonary fibrosis and fibrostenotic Crohn’s disease
CMO Dr Jane Robertson shares a sneak peek into trial designs for assets in IPF and Crohn’s disease planned for 2023/2024.
Zentalis and Pfizer to begin Phase I/II colorectal cancer therapy trial
Erasca and Pfizer enter trial partnership for palbociclib
Palatin enrols first subject in Phase II ulcerative colitis therapy trial
Satisfai, Virgo, and Alimentiv to boost trials using AI-powered technology
Zealand Pharma reports data from Phase III short bowel syndrome trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
